A Fifty‐Two–Week, Randomized, Placebo‐Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis

OBJECTIVE: The natural history of nonradiographic axial spondyloarthritis (SpA) is incompletely characterized, and there are concerns that nonsteroidal antiinflammatory drugs provide inadequate disease control in patients with active disease. This study was undertaken to investigate the effects of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Deodhar, Atul, Gensler, Lianne S., Kay, Jonathan, Maksymowych, Walter P., Haroon, Nigil, Landewé, Robert, Rudwaleit, Martin, Hall, Stephen, Bauer, Lars, Hoepken, Bengt, de Peyrecave, Natasha, Kilgallen, Brian, van der Heijde, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619287/
https://www.ncbi.nlm.nih.gov/pubmed/30848558
http://dx.doi.org/10.1002/art.40866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619287/
https://www.ncbi.nlm.nih.gov/pubmed/30848558
http://dx.doi.org/10.1002/art.40866

Ejemplares similares